Regional variation in the effects of nicotine on catecholamine overflow in rat brain

European Journal of Pharmacology

Volumn 325, Issue 1, 1997, Pages 13-20

  Benwell, Maureen E M ^a   Balfour, David J K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Dopamine; Hippocampus ventral; Nicotine; Noradrenaline; Nucleus accumbens; Striatum

Indexed keywords

DOPAMINE; NICOTINE; NOMIFENSINE; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOSE RESPONSE; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; GANGLIONIC STIMULANTS; HIPPOCAMPUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NICOTINE; NOMIFENSINE; NOREPINEPHRINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TETRODOTOXIN;

EID: 0030933175     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00101-5     Document Type: Article

References (35)

1. Abercrombie, E.D., K.A. Keefe, D.S. Di Frischia and M.J. Zigmond, 1989, Differential effects of stress on in vivo dopamine release in the striatum, nucleus accumbens and medial prefrontal cortex, J. Neurochem. 52, 1655.
2. Benowitz, N.L., H. Porchet and P. Jacob III, 1990, Pharmacokinetics, metabolism and pharmacodynamics of nicotine, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 112.
3. Benwell, M.E.M. and D.J.K. Balfour, 1992, The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine, and locomotor activity, Br. J. Pharmacol. 105, 849.
4. Benwell, M.E.M., D.J.K. Balfour and J.M. Anderson, 1988, Evidence that smoking increases the density of nicotine binding sites in human brain, J. Neurochem. 50, 1243.
5. Benwell, M.E.M., D.J.K. Balfour and H.M. Lucchi, 1993, Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine, Psychopharmacology 112, 467.
6. Benwell, M.E.M., D.J.K. Balfour and C.E. Birrell, 1995, Desensitisation of nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine, Br. J. Pharmacol. 114, 454.
7. Birrell, C.E. and D.J.K. Balfour, 1995, Studies on the mechanisms underlying sensitisation of the mesoaccumbens dopamine response to nicotine in the rat, Br. J. Pharmacol. 116, 337 pp.
8. Brazell, M.P., S.N. Mitchell, M.H. Joseph and J.A. Gray, 1990, Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4,dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with Caudate-Putamen, Neuropharmacology 29, 1177.
9. Clarke, P.B.S., 1990, Dopaminergic mechanisms in the locomotor stimulant effects of nicotine, Biochem. Pharmacol. 40, 1427.
10. Clarke, P.B.S. and A. Pert, 1985, Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurones, Brain Res. 348, 355.
11. Clarke, P.B.S., D.S. Fu, A. Jakubovic and H.C. Fibiger, 1988, Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant actions of nicotine in rats, J. Pharmacol. Exp. Ther. 246, 701.
12. Corrigall, W.A and K.M. Coen, 1991, Selective dopamine antagonist reduce nicotine self-administration, Psychopharmacology 104, 171.
13. Corrigall, W.A, K.B.J. Franklin, K.M. Coen and P.B.S. Clarke, 1992, The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine, Psychopharmacology 107, 285.
14. Corrigall, W.A., K.M. Coen and K.L. Adamson, 1994, Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area, Brain Res. 653, 278.
15. Di Chiara, G. and A. Imperato, 1988, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. USA 85, 5274.
16. Garris, P.A. and R.M. Wightman, 1994, Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex and striatum: an in vivo voltammetric study, J. Neurosci. 14, 442.
17. Giorgieff-Chesselet, M.F., M.L. Kemel, D. Wanscheer and J. Glowinski, 1979, Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effects of nicotine in a low concentration, Life Sci. 25, 1257.
18. Grenhoff, J. and T.H. Svensson, 1988, Selective stimulation of limbic dopamine activity by nicotine, Acta Physiol. Scand. 133, 595.
19. Imperato, A., A. Mulas and G. Di Chiara, 1986, Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats, Eur. J. Pharmacol. 132, 337.
20. Marks, M.J. and A.C. Collins, 1985, Tolerance, cross-tolerance and receptors after chronic nicotine or oxotremorine, Pharmacol. Biochem. Behav. 22, 283.
21. Marks, M.J., J.B. Burch and A.C. Collins, 1983, Effects of chronic nicotine infusions on tolerance development and nicotinic receptors, J. Pharmacol. Exp. Ther. 226, 817.
22. Marshall, J.F., S.J. O'Dell, R. Navarrete and A.J. Rosenstein, 1990, Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum, Neuroscience 37, 11.
23. Mereu, G., K.-W.P. Yoon, V. Boi, G.L. Gessa, L. Neas and T.C. Westfall, 1987, Preferential stimulation of ventral tegmental area dopaminergic neurones by nicotine, Eur. J. Pharmacol. 141, 395.
24. Mitchell, S.N., 1993, Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine, Neuropharmacology 32, 937.
25. Nisell, M., G.G. Nomikos and T.H. Svensson, 1994, Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area, Synapse 16, 36.
26. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, Sydney).
27. Rapier, C., G.G. Lunt and S. Wonnacott, 1988, Nicotinic modulation of dopamine release from striatal synaptosomes: pharmacological characterisation, J. Neurochem. 54, 937.
28. Russell, M.A.H., 1990, Nicotine intake and its control over smoking, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 374.
29. 3H)acetylcholine recognition sites in brain by nicotinic cholinergic drugs, J. Neurochem. 45, 427.
30. Singer, G., M. Wallace and R. Hall, 1982, Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat, Pharmacol. Biochem. Behav. 17, 579.
31. Somjet, C.G., Allen, B.W., Balestrino, M. and Aitken, P. (1987) Patho-physiology of pH and calcium in blood stream and brain, Can. J. Physiol. Pharmacol. 65, 1078.
32. Vale, A.L. and D.J.K. Balfour, 1989, Aversive environmental stimuli as a factor in the psychostimulant response to nicotine, Pharmacol. Biochem. Behav. 32, 857.
33. Wada, E., K. Wada, J. Boulter, E. Deneris, S. Heinemann, J. Patrick and L.W. Swanson, 1989, Distribution of alpha2, alpha3, alpha4 and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridisation histochemical study in the rat, J. Comp. Neurol. 284, 314.
34. Westerink, B.H.C., Hofsteede, H.M., Damsma, G. and De Vries, J.B. (1988) The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis, Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 373.
35. Wonnacott, S., 1990, Characterization of nicotine receptor sites in brain, in: Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, eds. S. Wonnacott, M.A.H. Russell and I.P. Stolerman (Oxford University Press, Oxford) p. 226.